Loading
IARC estimates 1,139 new cancer cases and 468 cancer deaths in New Caledonia in 2024; the commonest new cancers are trachea, bronchus and lung, breast and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for New Caledonia's mortality estimate is 3b: national incidence estimates applied to model-based mortality-to-incidence ratios (neighbouring country registry data). Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 190 | 43.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Breast | 174 | 84.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 170 | 79.7 | Prostate cancer |
| Colorectum | 88 | 20.0 | Colorectal cancer |
| Thyroid | 41 | 10.9 | Thyroid cancer |
| Liver and intrahepatic bile ducts | 37 | 8.7 | Hepatocellular carcinoma |
| Bladder | 36 | 7.4 | Bladder & urothelial cancer |
| Stomach | 34 | 7.4 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 33 | 7.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Corpus uteri | 32 | 15.2 | Endometrial cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 139 | 31.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Breast | 38 | 17.0 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Liver and intrahepatic bile ducts | 32 | 7.3 | Hepatocellular carcinoma |
| Colorectum | 30 | 6.5 | Colorectal cancer |
| Stomach | 26 | 5.8 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 24 | 5.2 | Pancreatic ductal adenocarcinoma |
| Prostate | 21 | 8.6 | Prostate cancer |
| Bladder | 12 | 2.3 | Bladder & urothelial cancer |
| Non-Hodgkin lymphoma | 11 | 2.2 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Leukaemia | 11 | 2.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
No trial record in OnCo lists a site in New Caledonia. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in New Caledonia.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. New Caledonia is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
New Caledonia is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.